An International Randomized Multicenter Comparison of Nasal Potential Difference Techniques-Reference-Cited by-同舟云学术

An International Randomized Multicenter Comparison of Nasal Potential Difference Techniques

Published:2010-10 Issue:4 Volume:138 Page:919-928
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Solomon George M.,Konstan Michael W.,Wilschanski Michael,Billings Joanne,Sermet-Gaudelus Isabelle,Accurso Frank,Vermeulen François,Levin Elina,Hathorne Heather,Reeves Ginger,Sabbatini Gina,Hill Aubrey,Mayer-Hamblett Nicole,Ashlock Melissa,Clancy John Paul,Rowe Steven M.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference25 articles.

1. Cystic fibrosis;Rowe;N Engl J Med,2005

2. Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis;Knowles;N Engl J Med,1981

3. Relative ion permeability of normal and cystic fibrosis nasal epithelium;Knowles;J Clin Invest,1983

4. A European consensus for the evaluation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis;Mayell;J Cyst Fibros,2009

5. The diagnosis of cystic fibrosis: a consensus statement;Rosenstein;J Pediatr,1998

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Calcium-sensing receptor (CaSR) modulates ocular surface chloride transport and its inhibition promotes ocular surface hydration;The Ocular Surface;2024-10

2. Alcohol-Induced Mucociliary Dysfunction: Role of Defective CFTR Channel Function;2023-07-19

3. Assessing accuracy of testing and diagnosis in cystic fibrosis;Expert Review of Respiratory Medicine;2023-05-04

4. Personalized medicine with drugs targeting the underlying protein defect in cystic fibrosis: is monitoring of treatment response necessary?;Therapeutic Advances in Chronic Disease;2022-01

5. Riociguat for the treatment of Phe508del homozygous adults with cystic fibrosis;Journal of Cystic Fibrosis;2021-11